This post originally appeared on Fast Data Science’s blog on LinkedIn.
Clinical trials, the backbone of medical science advancement, often grapple with high costs, complexity, and lengthy timelines. Fast Data Science presents Fast Clinical AI, a game-changing solution that harnesses the power of Natural Language Processing (NLP) and predictive modelling to tackle these challenges head-on.
Fast Clinical AI automates the extraction of critical information from trial protocols, significantly reducing manual efforts. This tool identifies risk factors and predicts costs and enrolment criteria, ensuring efficient trial planning and execution.
By identifying potential risks early in the trial process, Fast Clinical AI allows researchers to take proactive measures, minimising the chances of trial delays or failures. This proactive approach ensures that trials are faster and more reliable.
Fast Clinical AI helps predict and manage the costs associated with clinical trials, ensuring better resource allocation. Reducing manual efforts and streamlining processes significantly reduces the time required to bring new treatments to market.
Explore how Fast Clinical AI can revolutionise your clinical trials. Visit here for more details. Learn more about clinical trial cost modelling with NLP and AI here. Connect with us today to see how we can support your clinical trial efforts. Let’s innovate together!
#ClinicalTrials #AI #NLP #HealthcareInnovation #FastClinicalAI
Guest post by Youssef Soliman, medical student at Assiut University and biostatistician Designing a high-quality clinical trial protocol is critical for the success of any study. A protocol is the blueprint that outlines every aspect of a trial. In an ideal world, a flawless protocol would require no revisions and include only essential elements. In reality, however, the average protocol undergoes 2–3 amendments and often contains excessive data collection and overly complex entry criteria.
Clinical trials have long been the foundation of medical breakthroughs, but traditional methods often stumble over slow timelines, high costs, and difficulties in finding the right participants. Artificial intelligence (AI) — a technology ready to transform this landscape by making trials faster, more affordable, and smarter. The accelerating adoption of AI in clinical trials signals a major shift in healthcare research. It is already making significant strides in transforming clinical trials.
Guest post by Safeer Khan, Lecturer at Department of Pharmaceutical Sciences, Government College University, Lahore, Pakistan In clinical trials, a staggering 80% encounter delays during the startup phase and 37% struggle to meet enrollment targets. Read more Key clinical trial statistics. These figures highlight a critical, yet often underemphasized, aspect of clinical trials—the feasibility process. The feasibility process is essential for assessing the practicality of a clinical trial’s design, ensuring the study is prepared to tackle the challenges that may arise.